In this interview with Andrew Kleuss on Investors Hub, Vitaliy makes the case that concerns over Amazon’s entry into the pharmaceuticals business are probably overblown. To parse this problem, Vitaliy differentiates between pharmacies and drug distributors, and analyzes the extent to which Amazon can compete with both. While Amazon might place some pressure on pharmacies over time, he explains how drug distributors’ unique supply chains should remain robust against a competitive threat from Amazon.
Related Articles
A Balanced Life: My Approach – Ep 238
📩 Join 91,000+ readers on my FREE weekly email newsletter: 📚 Get my books: Soul in the Game - The Little Book of Sideways Markets - Active Value Investing - WHO AM I: Vitaliy Katsenelson is the CEO of...
Choosing an Investment Manager: Beyond Warren and Charlie – Ep 237
If you were obliged to invest all your investable assets with one person and you couldn’t choose Warren or Charlie, whom would you pick? 📩 Join 90,000+ readers on my FREE weekly email newsletter: 📚 Get my books: Soul in the Game...
Q&A Series: On Parenting and Personal Growth – Ep 236
📩 Join 90,000+ readers on my FREE weekly email newsletter: 📚 Get my books: Soul in the Game - The Little Book of Sideways Markets - Active Value Investing - WHO AM I: Vitaliy Katsenelson is the CEO of...
Challenging Investment Rules and Key Investor Traits – Ep 235
📩 Join 89,000+ readers on my FREE weekly email newsletter: 📚 Get my books: Soul in the Game - The Little Book of Sideways Markets - Active Value Investing - WHO AM I: Vitaliy Katsenelson is the CEO of...
0 comments